Cargando…
Discordant results between radioligand and immunohistochemical assays for steroid receptors in breast carcinoma.
Surgical biopsy specimens of 179 breast carcinoma were studied by steroid-binding and immunohistochemical assays or oestrogen and progesterone receptors (ER, PR) in order to explore reasons for discordant results between the two assay types. Receptor statuses in 18% of ER assays and 30% of PR assays...
Autores principales: | Helin, H., Isola, J., Helle, M., Koivula, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971742/ https://www.ncbi.nlm.nih.gov/pubmed/2202418 |
Ejemplares similares
-
Optimum Conditions of Radioligand Receptor Binding Assay of Ligands of Benzodiazepine Receptors
por: Ahmadi, Fatemeh, et al.
Publicado: (2014) -
A radioligand binding assay for the insulin-like growth factor 2 receptor
por: Potalitsyn, Pavlo, et al.
Publicado: (2020) -
Discordance of immunohistochemical markers between primary and recurrent or metastatic breast cancer: A retrospective analysis of 107 cases
por: Peng, Li, et al.
Publicado: (2020) -
Correlation between PET/CT results and histological and
immunohistochemical findings in breast carcinomas
por: Bitencourt, Almir Galvão Vieira, et al.
Publicado: (2014) -
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [(177)Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome
por: Hartrampf, Philipp E., et al.
Publicado: (2021)